Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6954)
All Articles published online
|
Publishing Process of This Article
|
Feb 27, 2015 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Pang TC, Lam VW. Surgical management of hepatocellular carcinoma. World J Hepatol 2015; 7(2): 245-252 [PMID: 25729479 DOI: 10.4254/wjh.v7.i2.245] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i2/245.htm |
| Number | Citing Articles |
| 1 |
Ying Zhang, Tao Li, Yumin Qiu, Tao Zhang, Pengbo Guo, Xiaomin Ma, Qing Wei, Lihui Han. Serum microRNA panel for early diagnosis of the onset of hepatocellular carcinoma. Medicine 2017; 96(2): e5642 doi: 10.1097/MD.0000000000005642
|
| 2 |
Michelle Ju, Adam C. Yopp. The Utility of Anatomical Liver Resection in Hepatocellular Carcinoma: Associated with Improved Outcomes or Lack of Supportive Evidence?. Cancers 2019; 11(10): 1441 doi: 10.3390/cancers11101441
|
| 3 |
Peng Sheng Yi, Yong Li, Shu Yan, Bin Wu, Chuan Lan, Jian Shui Li. Surgery combined with post-operative trancatheter arterial chemoembolization improves survival of intermediate hepatocellular carcinoma. Scandinavian Journal of Gastroenterology 2019; 54(2): 240 doi: 10.1080/00365521.2019.1577487
|
| 4 |
Guang‐Tao Min, Yu‐Min Li, Nan Yao, Jun Wang, Hong‐Peng Wang, Wei Chen. The pretreatment neutrophil‐lymphocyte ratio may predict prognosis of patients with liver cancer: A systematic review and meta‐analysis. Clinical Transplantation 2018; 32(1) doi: 10.1111/ctr.13151
|
| 5 |
Xiaoqin Wu, Bin Zhao, Yahui Cheng, Yang Yang, Cheng Huang, Xiaoming Meng, Baoming Wu, Lei Zhang, Xiongwen Lv, Jun Li. Melittin induces PTCH1 expression by down-regulating MeCP2 in human hepatocellular carcinoma SMMC-7721 cells. Toxicology and Applied Pharmacology 2015; 288(1): 74 doi: 10.1016/j.taap.2015.07.010
|
| 6 |
Keunyoung Kim, Seong-Jang Kim. Diagnostic test accuracies of F-18 FDG PET/CT for prediction of microvascular invasion of hepatocellular carcinoma: A meta-analysis. Clinical Imaging 2021; 79: 251 doi: 10.1016/j.clinimag.2021.06.015
|
| 7 |
Horatio R. Thomas, Mary Feng. Stereotactic Body Radiation Therapy (SBRT) in Hepatocellular Carcinoma. Current Hepatology Reports 2021; 20(1): 12 doi: 10.1007/s11901-020-00559-1
|
| 8 |
Marwa Matboli, Ayman E Shafei, Mahmoud A Ali, Ahmed M Ashry, Kamal M Kamal, Mohammed Ali Agag, Ibrahim Reda, Eman Fathy Tash, Marwa Ali. circRNAs (hsa_circ_00156, hsa_circ _000224, and hsa_circ _000520) are novel potential biomarkers in hepatocellular carcinoma. Journal of Cellular Biochemistry 2019; 120(5): 7711 doi: 10.1002/jcb.28045
|
| 9 |
Gonzalo Sapisochin, Jordi Bruix. Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches. Nature Reviews Gastroenterology & Hepatology 2017; 14(4): 203 doi: 10.1038/nrgastro.2016.193
|
| 10 |
Che-Yu Hsu, Chun-Wei Wang, Ann-Lii Cheng, Sung-Hsin Kuo. Hypofractionated particle beam therapy for hepatocellular carcinoma–a brief review of clinical effectiveness. World Journal of Gastrointestinal Oncology 2019; 11(8): 579-588 doi: 10.4251/wjgo.v11.i8.579
|
| 11 |
Roberto Mazzanti, Umberto Arena, Renato Tassi. Hepatocellular carcinoma: Where are we?. World Journal of Experimental Medicine 2016; 6(1): 21-36 doi: 10.5493/wjem.v6.i1.21
|
| 12 |
Yuan Zhang, Min Ding, Jia-chang Chi, Tao Wang, Yao-ping Shi, Bo Zhai. The early evaluation of ultrasound-guided iodine-125 interstitial implants for high-risk hepatocellular carcinoma. Brachytherapy 2019; 18(5): 733 doi: 10.1016/j.brachy.2019.05.011
|
| 13 |
Keisuke Arai, Takumi Fukumoto, Motofumi Tanaka, Kaori Kuramitsu, Masahiro Kido, Hisoka Kinoshita, Taku Matsumoto, Hirochika Toyama, Sadaki Asari, Tadahiro Goto, Tetsuo Ajiki, Yonson Ku. Pathological complete response after percutaneous isolated hepatic perfusion in hepatocellular carcinoma with portal vein tumor thrombosis: a case report. Surgical Case Reports 2016; 2(1) doi: 10.1186/s40792-016-0178-x
|
| 14 |
Yanyan Qian, Hongmeng Su, Yanping Ge, Kai Lei, Yiping Li, Hong Fan. Prognostic value of PD-L1 expression combined with hypoxia-associated immunosuppression in hepatocellular carcinoma. Biomarkers in Medicine 2022; 16(6): 435 doi: 10.2217/bmm-2021-1051
|
| 15 |
Yujia Xia, Zachary J. Brown, Hai Huang, Allan Tsung. Metabolic reprogramming of immune cells: Shaping the tumor microenvironment in hepatocellular carcinoma. Cancer Medicine 2021; 10(18): 6374 doi: 10.1002/cam4.4177
|
| 16 |
Zheng-Guang Xu, Cheng-Jie Ye, Lin-Xun Liu, Gang Wu, Zhan-Xue Zhao, Yong-Zhen Wang, Bing-Qiang Shi, Yong-Hong Wang. The pretransplant neutrophil-lymphocyte ratio as a new prognostic predictor after liver transplantation for hepatocellular cancer: a systematic review and meta-analysis. Biomarkers in Medicine 2018; 12(2): 189 doi: 10.2217/bmm-2017-0307
|
| 17 |
Michael Bitzer, Sabrina Groß, Jörg Albert, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, Achim Kautz, David Krug, Christian La Fougère, Hauke Lang, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Johann Ockenga, Karl Oldhafer, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Ulrike Ritterbusch, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans Jürgen Schlitt, Irene Schmid, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Reina Tholen, Jörg Trojan, Ingo van Thiel, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek. S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Langversion. Zeitschrift für Gastroenterologie 2023; 61(04): e92 doi: 10.1055/a-2026-1240
|
| 18 |
Alyson P Black, Anand S Mehta. The search for biomarkers of hepatocellular carcinoma and the impact on patient outcome. Current Opinion in Pharmacology 2018; 41: 74 doi: 10.1016/j.coph.2018.04.002
|
| 19 |
Joseph Asemota, Mohammed Saleh, Osato Igbinovia, Danny Burns. A Concise Review on Current Trends in Imaging and Surgical Management of Hepatocellular Carcinoma. Cureus 2020; doi: 10.7759/cureus.9191
|
| 20 |
Young-In Yoon, Sung-Gyu Lee. Living Donor Liver Transplantation for Hepatocellular Carcinoma: An Asian Perspective. Digestive Diseases and Sciences 2019; 64(4): 993 doi: 10.1007/s10620-019-05551-4
|
| 21 |
|
| 22 |
H.Y.-h. Liu, Y.-y.D. Lee, S. Sridharan, W. Wang, R. Khor, J. Chu, A. Oar, E.S. Choong, H. Le, M. Shanker, A. Wigg, K. Stuart, D. Pryor. Definitive Stereotactic Body Radiation Therapy in Early-Stage Solitary Hepatocellular Carcinoma: An Australian Multi-Institutional Review of Outcomes. Clinical Oncology 2023; 35(12): 787 doi: 10.1016/j.clon.2023.08.012
|
| 23 |
Jian-Feng Yang, Zhen-Hua Zhao, Yu Zhang, Li Zhao, Li-Ming Yang, Min-Ming Zhang, Bo-Yin Wang, Ting Wang, Bao-Chun Lu. Dual-input two-compartment pharmacokinetic model of dynamic contrast-enhanced magnetic resonance imaging in hepatocellular carcinoma. World Journal of Gastroenterology 2016; 22(13): 3652-3662 doi: 10.3748/wjg.v22.i13.3652
|
| 24 |
Soo‐Ho Lee, Jun‐Suh Lee, Gun‐Hyung Na, Young‐Kyoung You, Dong‐Goo Kim. Immunohistochemical markers for hepatocellular carcinoma prognosis after liver resection and liver transplantation. Clinical Transplantation 2017; 31(1) doi: 10.1111/ctr.12852
|
| 25 |
Takayuki Shimizu, Mitsuru Ishizuka, Takashi Suzuki, Genki Tanaka, Kyung Hwa Park, Takatsugu Matsumoto, Takayuki Shiraki, Yuhki Sakuraoka, Masato Kato, Taku Aoki, Keiichi Kubota. The preoperative globulin‐to‐albumin ratio, a novel inflammation‐based prognostic system, predicts survival after potentially curative liver resection for patients with hepatocellular carcinoma. Journal of Surgical Oncology 2017; 116(8): 1166 doi: 10.1002/jso.24772
|
| 26 |
Christian P. Strassburg. HCC-Associated Liver Transplantation - Where Are the Limits and What Are the New Regulations?. Visceral Medicine 2016; 32(4): 263 doi: 10.1159/000446385
|
| 27 |
Gloria Y. Chang, Adam C. Yopp. Expanding Indications for Surgical Resection in Hepatocellular Carcinoma. Surgical Oncology Clinics of North America 2024; 33(1): 99 doi: 10.1016/j.soc.2023.07.004
|
| 28 |
Michelle R. Ju, Adam C. Yopp. Evolving thresholds for liver transplantation in hepatocellular carcinoma: A Western experience. Annals of Gastroenterological Surgery 2020; 4(3): 208 doi: 10.1002/ags3.12316
|
| 29 |
Ahmed Omar Kaseb, Luis Vence, Jorge Blando, Shalini S. Yadav, Naruhiko Ikoma, Roberto Carmagnani Pestana, Jean Nicolas Vauthey, James P. Allison, Padmanee Sharma. Immunologic Correlates of Pathologic Complete Response to Preoperative Immunotherapy in Hepatocellular Carcinoma. Cancer Immunology Research 2019; 7(9): 1390 doi: 10.1158/2326-6066.CIR-18-0605
|
| 30 |
Satoshi Omiya, Takeshi Urade, Shohei Komatsu, Masahiro Kido, Kaori Kuramitsu, Hiroaki Yanagimoto, Hirochika Toyama, Takumi Fukumoto. Impact of GLIM criteria-based malnutrition diagnosis on outcomes following liver resection for hepatocellular carcinoma. HPB 2023; 25(12): 1555 doi: 10.1016/j.hpb.2023.08.012
|
| 31 |
Po-Lung Cheng, Ping-Hsiu Wu, We-Yu Kao, Yen-Ting Lai, Jason C. Hsu, Jeng-Fong Chiou, Meng-Huang Wu, Hsin-Lun Lee. Comparison of local ablative therapies, including radiofrequency ablation, microwave ablation, stereotactic ablative radiotherapy, and particle radiotherapy, for inoperable hepatocellular carcinoma: a systematic review and meta-analysis. Experimental Hematology & Oncology 2023; 12(1) doi: 10.1186/s40164-023-00400-7
|
| 32 |
Sabrina Groß, Michael Bitzer, Jörg Albert, Susanne Blödt, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Markus Follmann, Paul Freudenberger, Cihan Gani, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, David Krug, Christian La Fougère, Hauke Lang, Thomas Langer, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Monika Nothacker, Johann Ockenga, Karl Oldhafer, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Ulrike Ritterbusch, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans J. Schlitt, Irene Schmid, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Nadine Steubesand, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Reina Tholen, Jörg Trojan, Ingo van Thiel, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek. S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Langversion 4.0. Zeitschrift für Gastroenterologie 2024; 62(02): e213 doi: 10.1055/a-2189-8567
|
| 33 |
Keisuke Arai, Takumi Fukumoto, Masahiro Kido, Motofumi Tanaka, Kaori Kuramitsu, Hisoka Kinoshita, Shohei Komatsu, Daisuke Tsugawa, Sachio Terai, Taku Matsumoto, Tadahiro Goto, Sadaki Asari, Hirochika Toyama, Tetsuo Ajiki, Yonson Ku. Preoperative neutrophil-to-lymphocyte ratio as a predictor of survival after reductive surgery plus percutaneous isolated hepatic perfusion for hepatocellular carcinoma: a retrospective analysis. Surgery Today 2017; 47(3): 385 doi: 10.1007/s00595-016-1384-7
|
| 34 |
Jasmin Zeindler, Gabriel Fridolin Hess, Maximilian von Heesen, Noa Aegerter, Cornelia Reber, Andreas Michael Schmitt, Simone Muenst, Martin Bolli, Savas Deniz Soysal, Otto Kollmar. Anatomic versus non‐anatomic liver resection for hepatocellular carcinoma—A European multicentre cohort study in cirrhotic and non‐cirrhotic patients. Cancer Medicine 2024; 13(5) doi: 10.1002/cam4.6981
|
| 35 |
Arno Kornberg, Martina Schernhammer, Helmut Friess. 18F-FDG-PET for Assessing Biological Viability and Prognosis in Liver Transplant Patients with Hepatocellular Carcinoma. Journal of Clinical and Translational Hepatology 2017; (XX): 1 doi: 10.14218/JCTH.2017.00014
|
| 36 |
Francesco Vasuri, Michela Visani, Giorgia Acquaviva, Thomas Brand, Michelangelo Fiorentino, Annalisa Pession, Giovanni Tallini, Antonia D’Errico, Dario de Biase. Role of microRNAs in the main molecular pathways of hepatocellular carcinoma. World Journal of Gastroenterology 2018; 24(25): 2647-2660 doi: 10.3748/wjg.v24.i25.2647
|
| 37 |
Po-Chien Shen, Wei-Chou Chang, Cheng-Hsiang Lo, Jen-Fu Yang, Meei-Shyuan Lee, Yang-Hong Dai, Chun-Shu Lin, Chao-Yueh Fan, Wen-Yen Huang. Comparison of Stereotactic Body Radiation Therapy and Transarterial Chemoembolization for Unresectable Medium-Sized Hepatocellular Carcinoma. International Journal of Radiation Oncology*Biology*Physics 2019; 105(2): 307 doi: 10.1016/j.ijrobp.2019.05.066
|
| 38 |
Nicole Nevarez, Adam Yopp. Challenging the Treatment Paradigm: Selecting Patients for Surgical Management of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. Journal of Hepatocellular Carcinoma 2021; : 851 doi: 10.2147/JHC.S291530
|
| 39 |
Voesch Sabrina, Bitzer Michael, Albert Jörg, Bartenstein Peter, Bechstein Wolf, Blödt Susanne, Brunner Thomas, Dombrowski Frank, Evert Matthias, Follmann Markus, La Fougère Christian, Freudenberger Paul, Geier Andreas, Gkika Eleni, Götz Martin, Hammes Elke, Helmberger Thomas, Hoffmann Ralf-Thorsten, Hofmann Wolf-Peter, Huppert Peter, Kautz Achim, Knötgen Gabi, Körber Jürgen, Krug David, Lammert Frank, Lang Hauke, Langer Thomas, Lenz Philipp, Mahnken Andreas, Meining Alexander, Micke Oliver, Nadalin Silvio, Nguyen Huu Phuc, Ockenga Johann, Oldhafer Karl-Jürgen, Paprottka Philipp, Paradies Kerstin, Pereira Philippe, Persigehl Thorsten, Plauth Mathias, Plentz Ruben, Pohl Jürgen, Riemer Jutta, Reimer Peter, Ringwald Johanna, Ritterbusch Ulrike, Roeb Elke, Schellhaas Barbara, Schirmacher Peter, Schmid Irene, Schuler Andreas, von Schweinitz Dietrich, Seehofer Daniel, Sinn Marianne, Stein Alexander, Stengel Andreas, Steubesand Nadine, Stoll Christian, Tannapfel Andrea, Taubert Anne, Trojan Jörg, van Thiel Ingo, Tholen Reina, Vogel Arndt, Vogl Thomas, Vorwerk Hilke, Wacker Frank, Waidmann Oliver, Wedemeyer Heiner, Wege Henning, Wildner Dane, Wittekind Christian, Wörns Marcus-Alexander, Galle Peter, Malek Nisar. S3-Leitlinie: Diagnostik und Therapie des hepatozellulären Karzinoms. Zeitschrift für Gastroenterologie 2022; 60(01): e56 doi: 10.1055/a-1589-7568
|
| 40 |
Po-Chien Shen, Wen-Yen Huang, Yang-Hong Dai, Cheng-Hsiang Lo, Jen-Fu Yang, Yu-Fu Su, Ying-Fu Wang, Chia-Feng Lu, Chun-Shu Lin. Radiomics-Based Predictive Model of Radiation-Induced Liver Disease in Hepatocellular Carcinoma Patients Receiving Stereo-Tactic Body Radiotherapy. Biomedicines 2022; 10(3): 597 doi: 10.3390/biomedicines10030597
|
| 41 |
Shohei Okazaki, Kei Shibuya, Shintaro Shiba, Tomoyuki Takura, Tatsuya Ohno. Cost-Effectiveness Comparison of Carbon-Ion Radiation Therapy and Transarterial Chemoembolization for Hepatocellular Carcinoma. Advances in Radiation Oncology 2024; 9(4): 101441 doi: 10.1016/j.adro.2024.101441
|
| 42 |
Connor A. West, Alyson P. Black, Anand S. Mehta. Hepatocellular Carcinoma. Molecular and Translational Medicine 2019; : 93 doi: 10.1007/978-3-030-21540-8_5
|
| 43 |
Stacey Prenner, Laura Kulik. Zakim and Boyer's Hepatology. 2018; : 668 doi: 10.1016/B978-0-323-37591-7.00046-X
|
| 44 |
Yunjiao Wang, Chuchu Peng, Zhigang Cheng, Ximei Wang, Lei Wu, Jingyi Li, Changsheng Huang, Qulian Guo, Hongwei Cai. The prognostic significance of preoperative neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma receiving hepatectomy: A systematic review and meta-analysis. International Journal of Surgery 2018; 55: 73 doi: 10.1016/j.ijsu.2018.05.022
|
| 45 |
G.K. Glantzounis, E. Tokidis, S.-P. Basourakos, E.E. Ntzani, G.D. Lianos, G. Pentheroudakis. The role of portal vein embolization in the surgical management of primary hepatobiliary cancers. A systematic review. European Journal of Surgical Oncology (EJSO) 2017; 43(1): 32 doi: 10.1016/j.ejso.2016.05.026
|
| 46 |
Yu-De Chu, Hsin-Yu Lai, Li-Mei Pai, Ya-Hui Huang, Yang-Hsiang Lin, Kung-Hao Liang, Chau-Ting Yeh. The methionine salvage pathway-involving ADI1 inhibits hepatoma growth by epigenetically altering genes expression via elevating S-adenosylmethionine. Cell Death & Disease 2019; 10(3) doi: 10.1038/s41419-019-1486-4
|
| 47 |
Lior Charach, Zusmanovitch Zusmanovitch, Gideon Charach. Hepatocellular Carcinoma. Part 3: Surgical and Medical Treatment. EMJ Hepatology 2017; : 89 doi: 10.33590/emjhepatol/10312792
|
| 48 |
Yu-De Chu, Hui-Fen Liu, Yi-Chen Chen, Chun-Hung Chou, Chau-Ting Yeh. WWOX-rs13338697 genotype predicts therapeutic efficacy of ADI-PEG 20 for patients with advanced hepatocellular carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.996820
|
| 49 |
Yufei Tian, Wei Yao, Dongyun He, Yingying Xu, Yiquan Li, Yilong Zhu, Jinbo Fang, Bing Bai, Xiao Li, Lili Sun, Ningyi Jin. A dual cancer-specific recombinant adenovirus suppresses the growth of liver cancer cells in vivo and in vitro. Anti-Cancer Drugs 2020; 31(2): 110 doi: 10.1097/CAD.0000000000000854
|
| 50 |
Arno Kornberg, Ulrike Witt, Martina Schernhammer, Jennifer Kornberg, Gueralp O. Ceyhan, Katharina Mueller, Helmut Friess, Katharina Thrum. Combining 18F-FDG positron emission tomography with Up-to-seven criteria for selecting suitable liver transplant patients with advanced hepatocellular carcinoma. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-14430-9
|
| 51 |
Hae Won Lee, Kyung-Suk Suh. Expansion of the criteria for living donor liver transplantation for hepatocellular carcinoma. Current Opinion in Organ Transplantation 2016; 21(2): 231 doi: 10.1097/MOT.0000000000000294
|
| 52 |
Pegah Golabi, Sofie Fazel, Munkhzul Otgonsuren, Mehmet Sayiner, Cameron T. Locklear, Zobair M. Younossi. Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities. Medicine 2017; 96(9): e5904 doi: 10.1097/MD.0000000000005904
|
| 53 |
Yu-De Chu, Tan-Chi Fan, Ming-Wei Lai, Chau-Ting Yeh. GALNT14-mediated O-glycosylation on PHB2 serine-161 enhances cell growth, migration and drug resistance by activating IGF1R cascade in hepatoma cells. Cell Death & Disease 2022; 13(11) doi: 10.1038/s41419-022-05419-y
|
| 54 |
HJ Lim, AKH Chiow, LS Lee, SS Tan, BKP Goh, YX Koh, CY Chan, SY Lee. Novel method of intraoperative liver tumour localisation with indocyanine green and near-infrared imaging. Singapore Medical Journal 2021; 62(4): 182 doi: 10.11622/smedj.2019137
|
| 55 |
Michael Bitzer, Sabrina Groß, Jörg Albert, Susanne Blödt, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Markus Follmann, Paul Freudenberger, Cihan Gani, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, David Krug, Christian La Fougère, Hauke Lang, Thomas Langer, Philipp Lenz, Tom Lüdde, Andreas Mahnken, Silvio Nadalin, Hoa Huu Phuc Nguyen, Monika Nothacker, Johann Ockenga, Karl Oldhafer, Philipp Paprottka, Philippe Pereira, Thorsten Persigehl, Ruben Plentz, Jürgen Pohl, Heinrich Recken, Peter Reimer, Jutta Riemer, Ulrike Ritterbusch, Elke Roeb, Jörn Rüssel, Barbara Schellhaas, Peter Schirmacher, Hans Jürgen Schlitt, Irene Schmid, Andreas Schuler, Daniel Seehofer, Marianne Sinn, Andreas Stengel, Nadine Steubesand, Christoph Stoll, Andrea Tannapfel, Anne Taubert, Reina Tholen, Jörg Trojan, Ingo van Thiel, Arndt Vogel, Thomas Vogl, Frank Wacker, Oliver Waidmann, Heiner Wedemeyer, Henning Wege, Dane Wildner, Marcus-Alexander Wörns, Peter Galle, Nisar Malek. S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Langversion 4.0. Zeitschrift für Gastroenterologie 2024; 62(01): e67 doi: 10.1055/a-2189-6353
|
| 56 |
Jin Shang, Shanling Xu, Jiaxing Zhang, Xuting Ran, Lang Bai, Hong Tang. Efficacy of sorafenib in patients with hepatocellular carcinoma after resection: a meta-analysis. Oncotarget 2017; 8(65): 109723 doi: 10.18632/oncotarget.21299
|
| 57 |
Xionghu Shen, Xian Cui, Hai Cui, Yongmin Jin, Wenbiao Jin, Honghua Sun. Geraniol and lupeol inhibit growth and promote apoptosis in human hepatocarcinoma cells through the MAPK signaling pathway. Journal of Cellular Biochemistry 2019; 120(4): 5033 doi: 10.1002/jcb.27779
|